ALKERMES (ALKS)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About ALKERMES
Alkermes plc is a biotechnology company listed on NASDAQ as ALKS that develops and commercializes central nervous system medicines and related drug-delivery capabilities. Its portfolio spans schizophrenia, addiction, bipolar disorder, and sleep disorders, and it generated $1.5 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ALKERMES's Technical Indicators Summary
ALKS presents a broadly bullish backdrop with the price above most moving averages, including materially higher long-term levels, even as short-term momentum is mixed with RSI near neutral and MACD slightly negative. ADX around the mid-20s points to a modest trending environment despite the indicator’s neutral bias, and ATR is moderate at about $1.8, indicating contained volatility. Notably, on-balance volume flags some distribution even as pivots sit below the current price, suggesting cautious strength. Technical takeaway: Strong Buy.
| Indicator | Value |
|---|---|
RSI (14) | 51.54 |
Stochastic %K (14, 3, 3) | 31.89 |
CCI (20) | -43.03 |
WPR (14) | -57.23 |
Momentum (10) | 1.98 |
MFI | 46.16 |
MACD Level (12, 26) | -0.17 |
Bollinger Bands | $47.33 - $54.03 |
ATR (14) | $1.82 (3.62%) |
ADX (14) | 26.05 |
OBV | 18,642,842 |
Classic Pivot Point | $49.44 |
Fibonacci Pivot Point | $49.44 |
Simple Moving Averages | $36.23 - $50.68(5 indicators) |
Exponential Moving Averages | $38.55 - $50.14(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Medium move higher: ALKS sits 2.03% above yesterday’s close (49.21). Volume has dried up to an unusually low 0.17× its norm. ALKS gains favorable terms as credit agreement amendment lowers interest rate spreads.
Trading Volume
Below 10d avg (1.5M)
245.8K
vs S&P 500 Today
Outperforming Market
+1.78%
52-Week Position
Upper range
82.1%
Updated: August 12, 2026 at 16:44 UTC